Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer

Rhea-AI Summary

Shoulder Innovations (NYSE: SI) announced the promotion of Jon Osborne to Chief Commercial Officer, effective August 6, 2026. He previously served as Vice President of Commercial Development and will now oversee all elements of the company’s commercial organization.

According to Shoulder Innovations, Osborne will work closely with the Customer Experience and Medical Education team to execute the company’s commercial strategy and support scaling adoption of its shoulder-focused product portfolio. He brings prior leadership experience from Smith & Nephew, ArthroCare, Tornier USA, and Team Surgical, with responsibilities across sales, global marketing, and commercial growth.

Market Context

Recent insider records showed Net Selling, with 188275 shares sold and none bought over 90 days. Tha...

Analysis

Recent insider records showed Net Selling, with 188275 shares sold and none bought over 90 days. That platform context frames the leadership change alongside an active, not-yet-effective S-3 and related resale registration.

Key Figures

Promotion Effective Date: August 6, 2026 Prior Role Start: September 2023 Smith & Nephew Tenure: 2014–2023 +2 more

5 metrics

Promotion Effective Date August 6, 2026 Chief Commercial Officer appointment

Prior Role Start September 2023 Joined Shoulder Innovations as Vice President of Commercial Development

Smith & Nephew Tenure 2014–2023 Held positions of increasing responsibility

Earlier Career Period 1998–2014 Sales management, global marketing, and general management roles

Distribution Reach six continents Products launched and distribution built at Smith & Nephew

Historical Context

5 past events · Latest: Jul 29 (Neutral)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Jul 29	Growth conference participation	Neutral	-2.2%	Management announced participation in the Canaccord Genuity Growth Conference.
Jul 14	Earnings date announcement	Neutral	+1.1%	Company scheduled release of second-quarter 2026 financial results.
Jun 29	Credit facility closing	Positive	-7.5%	Company closed credit facilities totaling up to $50 million.
May 26	Healthcare conference participation	Neutral	-0.6%	Management announced participation in the Goldman Sachs healthcare conference.
May 13	First-quarter earnings report	Positive	+15.2%	Company reported growth and raised its full-year 2026 revenue outlook.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

SI historically diverged negatively on several neutral or positive announcements, while its May earnings release aligned with a positive reaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

GRAND RAPIDS, Mich., Aug. 10, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced the promotion of Jon Osborne to Chief Commercial Officer, effective August 6, 2026. Mr. Osborne, who most recently served as Vice President of Commercial Development, will now have responsibility for all elements of Shoulder Innovations' commercial organization and will work closely with its Customer Experience and Medical Education team to execute the company's commercial strategy.

"Jon has consistently demonstrated exceptional leadership since joining Shoulder Innovations, and this promotion reflects the impact he's had on our rapid commercial success as a key architect of our go-to-market strategy," said Rob Ball, CEO of Shoulder Innovations. "His depth of experience across the orthopedic industry, paired with his keen understanding of our business, strong relationships with our surgeon customers, and proven ability to execute, positions him well to lead our commercial organization as we continue to scale adoption of our broad and increasingly differentiated product portfolio."

"We're at an exciting point in our early journey of transforming the shoulder surgical care market for our customers and their patients, and I'm looking forward to building on the strong commercial foundation that the entire Shoulder Innovations team has worked hard to build," said Jon Osborne. "With this expanded role, my focus will be on further scaling the organization, deepening our surgeon and partner relationships, and ensuring our commercial execution keeps pace with the strength of our innovation engine."

Prior to joining Shoulder Innovations as Vice President of Commercial Development in September 2023, Mr. Osborne held several positions of increasing responsibility from 2014 to 2023 at Smith & Nephew Inc., most recently as Vice President of Commercial Marketing for the Sports Medicine business in the Americas. In this role, he was responsible for driving growth across a portfolio spanning joint repair, arthroscopic enabling technologies, biologics, and capital equipment, with additional oversight for outpatient and ambulatory surgery center initiatives. Earlier in his career at Smith & Nephew Inc., he also served as an Area Vice President of Sales and as Director of Global Marketing, where he launched products and built distribution across six continents.

Prior to Smith & Nephew, Mr. Osborne worked in sales management, global marketing, and general management from 1998 to 2014 in both domestic and international markets at ArthroCare Corporation, Tornier USA, and Team Surgical, Inc. Mr. Osborne received his Bachelor of Arts in Public Relations from Miami University in Oxford, Ohio, and his Master of Business Administration from the Leeds School of Business at the University of Colorado.

About Shoulder Innovations
Shoulder Innovations is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, with a current offering of advanced implant systems for shoulder arthroplasty. These systems are a core element of Shoulder Innovations' ecosystem, which is designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain. Shoulder Innovations' ecosystem is also comprised of enabling technologies, efficient instrument systems, specialized support and surgeon-to-surgeon collaboration. Together, these elements seek to address the long-standing clinical and operational challenges in the shoulder surgical care market by delivering predictable outcomes, procedural simplicity, and efficiency across all sites of care.

Contact 
Brian Johnston or Sam Bentzinger
Gilmartin Group LLC
ir@shoulderinnovations.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/shoulder-innovations-promotes-jon-osborne-to-chief-commercial-officer-302846661.html

SOURCE Shoulder Innovations

FAQ

Who was promoted to Chief Commercial Officer at Shoulder Innovations (NYSE: SI) in August 2026?

Jon Osborne was promoted to Chief Commercial Officer at Shoulder Innovations, effective August 6, 2026. According to Shoulder Innovations, he previously served as Vice President of Commercial Development and will now be responsible for all elements of the company’s commercial organization and strategy execution.

What will Jon Osborne’s responsibilities be as Chief Commercial Officer of Shoulder Innovations (SI)?

As Chief Commercial Officer, Jon Osborne will oversee all aspects of Shoulder Innovations’ commercial organization. According to Shoulder Innovations, he will work closely with the Customer Experience and Medical Education team to execute the commercial strategy and support scaling adoption of the company’s shoulder surgical product portfolio.

What experience does Jon Osborne bring to his new role at Shoulder Innovations (SI)?

Jon Osborne brings extensive orthopedic and medical technology experience to his CCO role. According to Shoulder Innovations, he held senior positions at Smith & Nephew, including Vice President of Commercial Marketing for Sports Medicine, and previously worked in sales, global marketing, and general management at ArthroCare, Tornier USA, and Team Surgical.

When did Jon Osborne join Shoulder Innovations (NYSE: SI) before becoming Chief Commercial Officer?

Jon Osborne joined Shoulder Innovations in September 2023 as Vice President of Commercial Development. According to Shoulder Innovations, his promotion to Chief Commercial Officer became effective on August 6, 2026, reflecting his role as a key architect of the company’s go-to-market and commercial strategy.

What is the strategic focus of Shoulder Innovations that Jon Osborne will support as CCO?

Shoulder Innovations focuses exclusively on transforming the shoulder surgical care market. According to Shoulder Innovations, Jon Osborne’s role as Chief Commercial Officer centers on scaling the commercial organization, deepening surgeon and partner relationships, and aligning commercial execution with the company’s innovation-driven product portfolio.

What is Jon Osborne’s educational background relevant to his leadership role at Shoulder Innovations (SI)?

Jon Osborne holds a Bachelor of Arts in Public Relations from Miami University in Oxford, Ohio. According to Shoulder Innovations, he also earned a Master of Business Administration from the Leeds School of Business at the University of Colorado, supporting his commercial and leadership responsibilities.